JournalsHub
.online
Find My Journal
JC

Janet D. Culshaw

Independent Researcher

14
Publications
452
Citations
7
H-Index
7
i10-Index
0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models".

M. Finlay, M. Anderton, Andrew Bailey, S. Boyd, J. Brookfield - Journal of Medicinal Chemistry, 2023
Cited by 0 Semantic Scholar

Discovery of a Thiadiazole-Pyridazine Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models.

M. Finlay, M. Anderton, Andrew Bailey, S. Boyd, J. Brookfield - Journal of Medicinal Chemistry, 2019
Cited by 24 Semantic Scholar

Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma.

James S Scott, S. Degorce, R. Anjum, Janet D. Culshaw, Robert D. M. Davies - Journal of Medicinal Chemistry, 2017
Cited by 41 Semantic Scholar

A Concise Synthesis of Fused Tricyclic Pyrrolo[3,2-d]pyrimidines

J. Pink, Janet D. Culshaw - Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry, 2016
Cited by 3 Semantic Scholar

Discovery of AZD3147: a potent, selective dual inhibitor of mTORC1 and mTORC2.

K. Pike, Jeff Morris, Linette Ruston, Sarah L. Pass, Ryan D. R. Greenwood - Journal of Medicinal Chemistry, 2015
Cited by 24 Semantic Scholar

Synthesis of 3-Substituted 2-Aminopyridines via Displacement of 3-Fluoro-2-nitropyridine

Janet D. Culshaw, J. Eden, Susannah J. Ford, B. Hayter, David F. Perkins - Synlett : Accounts and Rapid Communications in Synthetic Organic Chemistry, 2012
Cited by 2 Semantic Scholar

Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitors.

Malcolm A. Anderson, David M. Andrews, Andrew J. Barker, C. Brassington, J. Breed - Bioorganic & Medicinal Chemistry Letters, 2008
Cited by 29 Semantic Scholar

Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5b

Malcolm A. Anderson, D. Andrews, A. Barker, C. Brassington, J. Breed - Unknown Venue, 2008
Cited by 0 Semantic Scholar

Imidazo[1,2-a]pyridines. Part 2: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors.

K. Byth, Janet D. Culshaw, S. Green, Sandra E. Oakes, Andrew P Thomas - Bioorganic & Medicinal Chemistry Letters, 2004
Cited by 108 Semantic Scholar

Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.

K. Byth, N. Cooper, Janet D. Culshaw, D. W. Heaton, Sandra E. Oakes - Bioorganic & Medicinal Chemistry Letters, 2004
Cited by 71 Semantic Scholar

Research Topics

Cancer-related Molecular Pathways (5) Synthesis and Reactivity of Heterocycles (5) Microtubule and mitosis dynamics (3) Advanced Breast Cancer Therapies (3) Cancer, Hypoxia, and Metabolism (2)

Affiliations

AstraZeneca (United Kingdom)
GB 2019 - 2003
AstraZeneca (France)
FR 2012 - 2012
AstraZeneca (Brazil)
BR 2016 - 2016

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now